Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use. Appendix D. Substance Use: Medication-assisted Treatment and Other Related Measures

11/25/2015

TABLE D.1. Substance Use: MAT and Other Related Measures
Measure Denominator Numerator Setting Data Source Developer/Steward
EFFECTIVE CLINICAL CARE
NQF #2597
Percentage of patients aged 18 years and older who were screened at least once within the last 24 months for tobacco use, unhealthy alcohol use, non-medical prescription drug use, and illicit drug use AND who received an intervention for all positive screening results.
All patients aged 18 years and older who were seen twice for any visits or who had at least 1 preventive care visit during the 12 month measurement period. Patients who received the following substance use screenings at least once within the last 24 months AND who received an intervention for all positive screening results:

Tobacco use component Patients who were screened for tobacco use at least once within the last 24 months AND who received tobacco cessation intervention if identified as a tobacco user.

Unhealthy alcohol use component .

Patients who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 24 months AND who received brief counseling if identified as an unhealthy alcohol user.

Drug use component (non-medical prescription drug use and illicit drug use).

Patients who were screened for non-medical prescription drug use and illicit drug use at least once within the last 24 months using a systematic screening method AND who received brief counseling if identified as a non-medical prescription drug user or illicit drug user.

Multiple, including ambulatory. Electronic clinical data. ASAM
Assessment for Substance Abuse Problems of Psychiatric Patients. Total number of patients in a plan who received psychiatric evaluations within a specified period of time. Number of patients in the denominator whose medical record indicates explicit evidence of assessment of current and/or past SUDs. Multiple, including ambulatory Administrative/Paper APA
SUDs: percentage of patients aged 18 years and older with a diagnosis of current substance abuse or dependence who were screened for depression within the 12 month reporting period. All patients aged 18 years and older with a diagnosis of current substance abuse or dependence. Patients who were screened for depression within the 12 month reporting period. Multiple, including ambulatory Administrative/Paper-based medical records APA
Assessment of SUD, and trauma and patient strengths completed. All psychiatric inpatient discharges with at least a 72 hour stay. Patients whose records include documentation of initial assessment completed:

Within 72 hours of admission:

  • Presence/absence of co-occurring SUD in past 12 months.
  • Presence/absence of history of psychological trauma and contribution of trauma to current presentation.
  • Assessment of patient strengths.
Inpatient. Administrative/paper-based medical records. VHA
Assessment of recent substance use--type, quantity and frequency. Patients in a new treatment episode. Patients in the denominator who have an assessment of recent substance abuse, including type, quantity, and frequency, within the first 30 days of the new treatment episode. Likely multiple. Administrative/paper-based medical records. VHA
Substance Abuse Detection. All enrollees in a health plan over a 12-month period x 1000. Those enrollees who received an alcohol or drug-related diagnosis or received at least 1 substance abuse related plan service during the same period. Multiple--Ambulatory, hospital. Administrative/paper-based medical records. Washington Circle Group
Proportion of patients with SUD diagnosis that received evidence-based CM or Contingency Contracting. Patients with SUD diagnosis who have at least 1 psychotherapy visit in the study period. Patients from the denominator who received:

a) Any evidence-based CM or Contingency Contracting in the study period.

b) The number of CM or Contingency Contracting visits received in the study period by the same provider in (a).

Unclear--Ambulatory and possibly inpatient. Administrative/paper-based medical records. VHA
Proportion of patients with SUD diagnosis that received evidence-based cognitive behavioral RPT by the first provider of RPT. Patients with SUD diagnosis who have at least 1 psychotherapy visit in the study period. Patients from the denominator who received:

a) Any evidence-based cognitive behavioral RPT in the study period.

b) The number of RPT visits received in the year following the first RPT encounter by the same provider in (a).

Unclear--Ambulatory and possibly inpatient. Administrative/paper-based medical records. VHA
Early discharge rates from residential care for SUD. SUD-related inpatient admissions during the study period for patients with cohort diagnosis of SUD. a) Inpatient admission in the denominator where patient was discharged from residential care for SUD within 1 week of admission.

b) Total length-of-stay in days per related inpatient admission for patients in the denominator discharged from residential care for SUD.

Inpatient, residential. Administrative. VHA
Program Completion for Chemical Dependency Treatment. Total number of clients who were discharged from a chemical dependency rehabilitation program during a specified period. Number of clients in the denominator who completed the program (i.e., their reason for discharge was "all or most treatment goals met" on PAS-45, Item 18). Rehabilitation program. Other. New York State Office of Alcoholism and Substance Abuse Services
Completion of Treatment for Substance Abuse. All patients discharged from a state-funded substance abuse treatment program during a specified interval, excluding those who have been reassessed as inappropriate for the program, discharged due to loss of program funding, or died. Patients from the denominator whose records contain a discharge note indicating they met at least 75% of:

(1) Their planned duration of stay (documented on the treatment plan).

(2) The behavioral objectives identified in their treatment plan.

State-funded substance abuse treatment program. Paper-based medical records. Texas Commission on Alcohol and Drug Abuse
Completion of Treatment for Substance Abuse (Child/Adolescents). All patients under 18 years of age discharged from a state-funded substance abuse treatment program during a specified interval, excluding those who have been reassessed as inappropriate for the program, discharged due to loss of program funding, or died. Patients from the denominator whose records contain a discharge note indicating they met at least 75% of:

(1) Their planned duration of stay (documented on the treatment plan).

(2) The behavioral objectives identified in their treatment plan.

State-funded substance abuse treatment program. Paper-based medical records. Texas Commission on Alcohol and Drug Abuse
1-Week Retention Rate for Chemical Dependency Treatment. Total number of clients discharged from an inpatient chemical dependency program during a specified period. Number of clients in the denominator who EITHER completed the program (i.e., their reason for discharge was "all or most treatment goals met" on PAS-45, Item 18) or had a length-of-stay in the program of 1 week or longer at time of discharge. Multiple, including ambulatory. Administrative/paper-based medical records. New York State Office of Alcoholism and Substance Abuse Services
1-Month Retention Rate for Chemical Dependency Treatment. Total number of clients discharged from an outpatient or residential chemical dependency treatment program during a specified period. Number of clients in the denominator who EITHER completed the program (i.e., their reason for discharge was "all or most treatment goals met" on PAS-45, Item 18) or had a length-of-stay in the program of 1 month or longer at time of discharge. Multiple, including ambulatory. Administrative/paper-based medical records. New York State Office of Alcoholism and Substance Abuse Services
60-Day Continuation of Substance Abuse Treatment. All plan members who are admitted to an inpatient, intensive outpatient, or alternative intensive setting for a primary diagnosis of substance abuse and have at least 1 claims-based encounter during a specified time period. [Patients with nicotine and caffeine disorders are excluded.] Patients in the denominator who remain in treatment after more than 60 days but less than 90 days following admission. Multiple, including ambulatory. Administrative. New York State Office of Alcoholism and Substance Abuse Services
3-Month Retention Rate for Chemical Dependency Treatment. Total number of clients discharged from an outpatient or residential chemical dependency treatment program during a specified period who EITHER completed the program or had a length-of-stay of 1 month or longer. Number of clients in the denominator who EITHER completed the program [i.e., their reason for discharge was "all or most treatment goals met" on PAS-45, Item 18] or had a length-of-stay in the program of 3 months or longer at time of discharge. Multiple, including ambulatory. Administrative/paper-based medical records. New York State Office of Alcoholism and Substance Abuse Services
1-Year Retention Rate for Chemical Dependency Treatment. Total number of clients who were discharged from an outpatient or residential chemical dependency treatment program who EITHER completed the program or had a length-of-stay of 1 month or longer during a specified period. Number of clients in the denominator who EITHER completed the program [i.e., their reason for discharge was "all or most treatment goals met" on PAS-45, Item 18] or had a length-of-stay in the program of 1 year or longer at time of discharge. Multiple, including ambulatory. Administrative/paper-based medical records. New York State Office of Alcoholism and Substance Abuse Services
Mental health: percent of patients beginning a new episode of treatment for SUD who maintain continuous treatment involvement for at least 90 days after qualifying date. Number of Veterans beginning specialty treatment for SUD. Number of Veterans beginning specialty treatment for SUD who maintain continuous treatment involvement for at least 90 days as demonstrated by at least 2 days with visits every 30 days for a total of 90 days in any of the outpatient specialty SUD clinics. Multiple, including ambulatory. Administrative/paper-based medical records. VHA
Substance Abuse Maintenance Treatment. The number of patients 18 and older in a health plan discharged from inpatient or outpatient treatment with primary or secondary diagnosis of an alcohol or drug disorder. The subset of patients from the denominator who report receiving specific services and/or monitoring by the plan to promote and sustain positive treatment outcomes post-discharge. Multiple, including ambulatory. Administrative/patient survey. Washington Circle Group
COMMUNICATION AND CARE COORDINATION
For selected SUD patients, mean time to initiation of appropriate follow-up SUD treatment. Patients with an SUD diagnosis in a new treatment episode. For those in the denominator:

a) Patients with any follow-up in the 90 days following the start of the new treatment episode.

b) For those patients with follow-up within 90 days, number of days until first outpatient follow-up visit.

Multiple, including ambulatory. Not specified. VHA
Proportion of patients with COD and severe functional impairment that receive integrated substance abuse and mental health treatment. a) Patients, with a COD and who have GAF score <40, who had at least 2 diagnosis-related visits during the study period.

b) Patients, with a COD and who have GAF score >40, who had at least 2 diagnosis-related visits during the study period.

c) Patients, with a COD and who have no reported GAF, who had at least 2 diagnosis-related visits during the study period.

Patients from the denominator who received treatment for both their mental health and SUD during the study period from:

a) 1 clinic team or clinician cross-trained in both mental health and SUD issues (e.g., IDDT)
OR
b) Separate clinic teams that are well coordinated (e.g., notes indicated active communication or knowledge that separate clinics were working with patient).
OR
c) Separate clinic teams not well coordinated (e.g., no communication between the 2 clinic teams or only a referral).
OR
d) Only received treatment for 1 condition.

Likely multiple. Administrative/paper-based medical records. VHA
Referral to Post-Detoxification Services. All patients discharged from a state-funded substance abuse treatment program. Patients from the denominator whose records contain documentation of completed detoxification and a referral or transfer to a less intensive level of treatment. State-funded substance abuse treatment program; likely inpatient. Paper-based medical records. Texas Commission on Alcohol and Drug Abuse
Outpatient Visit within 3 Days of Discharge (Substance Abuse). All inpatients discharged with a diagnosis of substance abuse during a 1 year period who remained in the community for at least 30 days following discharge. Those patients from the denominator who had 1 or more outpatient visits for a primary or secondary diagnosis of substance abuse within 3 days of their index discharge. Multiple, including ambulatory. Administrative. VA--Palo Alto Health Care System
14-Day Follow-up after Initiating Substance-related Treatment. The number of patients enrolled in a health plan during a specified interval who receive a service-related diagnosis of an alcohol or drug disorder. The subset of patients in the denominator who receive any additional alcohol or drug treatment services within 14 days of "index" diagnosis. Multiple, including ambulatory. Administrative/paper-based medical records. Washington Circle Group
Substance Abuse Treatment Following Detoxification. The number of patients 18 and older enrolled in a health plan who were diagnosed with a substance abuse or dependence disorder and discharged from detoxification treatment within a defined time period. The number of patients in the denominator who entered alcohol or drug treatment services within 14 days following discharge from detoxification treatment. Multiple, including ambulatory. Administrative/paper-based medical records. Washington Circle Group
NQF #2605
Follow-up after Discharge from the Emergency Department for Mental Health or AOD Dependence.
Patients who were treated and discharged from an emergency department with a primary diagnosis of mental health or AOD dependence on or between January 1 and December 1 of the measurement year. Rate 1: An outpatient visit, intensive outpatient encounter or partial hospitalization with any provider with a primary diagnosis of AOD dependence within 7 days after emergency department discharge.

Rate 2: An outpatient visit, intensive outpatient encounter or partial hospitalization with any provider with a primary diagnosis of AOD dependence within 30 days after emergency department discharge.

Multiple, including ambulatory. Administrative claims. NCQA
Attendance at First Post-Discharge Appointment. All patients discharged from an inpatient setting with a primary psychiatric or substance abuse disorder diagnosis who are scheduled for a follow-up outpatient appointment during a 1 month period. Patients from the denominator who attended their scheduled appointment. Multiple, including ambulatory. Administrative. None provided. The measure was found in the Center for Quality Assessment and Improvement in Mental Health's measures inventory.
Follow-up Attended within 30 Days of Discharge (Psychiatric/Substance Abuse). All patients discharged from an inpatient facility with a primary diagnosis of a psychiatric or SUD during the first 6 months of a specified year. Patients in the denominator who attend an outpatient visit within 30 calendar days of discharge. Multiple, including ambulatory Administrative Leslie et al., 2000. (No further information was provided.) The measure was found in the Center for Quality Assessment and Improvement in Mental Health's measures inventory.
Ambulatory Follow-up Attended within 30 Days of Discharge (Substance Abuse). The number of hospital discharges to a setting other than another inpatient facility (e.g., outpatient, partial or residential program) occurring during a specified period of time for plan members with a primary or secondary diagnosis indicating a substance-related disorder and who remain continuously enrolled in the plan for 30 days after discharge. The number of discharges in the denominator that are followed by an ambulatory substance abuse assessment or therapeutic encounter within 30 days of hospital discharge. Multiple, including ambulatory. Administrative. VHA
Outpatient Follow-up After First Substance Abuse Visit. The number of patients 18 and older enrolled in a health plan who receive a service-related diagnosis of a SUD. Patients from the denominator who receive:

(i) 1.
OR
(ii) 3 plan-provided alcohol or drug treatment services within 30 days following the index service.

Multiple, including ambulatory. Administrative/paper-based medical records. Washington Circle Group
Multiple Outpatient Visits after Substance-Related Hospitalization. All inpatients treated in substance abuse units during the FY who remained in the community for at least 30 days following their index discharge. Those patients from the denominator who had 2 or more outpatient mental health visits within 30 days of discharge. Multiple, including ambulatory. Administrative. VHA
Intensity of Aftercare within 180 Days of Discharge (Psychiatric/Substance Abuse). All patients admitted to a hospital and discharged with a primary diagnosis of a psychiatric or SUD during the first 6 months of a specified year. The number of outpatient visits attended by patients from the denominator during the first 180 days following inpatient discharge. Multiple, including ambulatory. Administrative. Leslie et al., 2000. (No further information was provided.) The measure was found in the Center for Quality Assessment and Improvement in Mental Health's measures inventory.
Follow-up Attended within 180 Days of Discharge (Psychiatric/Substance Abuse). All patients discharged from an inpatient setting with a primary diagnosis of a psychiatric or SUD during the first 6 months of a specified year. Patients in the denominator who attend an outpatient visit within 180 calendar days of discharge. Multiple, including ambulatory. Administrative. Leslie et al., 2000. (No further information was provided.) The measure was found in the Center for Quality Assessment and Improvement in Mental Health's measures inventory.
Continuity of Care for Dual Diagnoses. The number of inpatients discharged with diagnoses for both psychiatric and substance-related disorders. Those patients in the denominator who receive at least 4 psychiatric and 4 substance abuse outpatient visits within the 12-month period following discharge. Multiple, including ambulatory. Administrative. VHA
Care Planning for Dual Diagnosis. The number of individuals participating in a case management program who are dually diagnosed with a mental disorder and a substance abuse disorder during a 6-month period. Those individuals from the denominator for whom a case manager has documented a plan of care that addresses the consumer's need for treatment of both conditions. Multiple, including ambulatory. Administrative/paper-based medical records. None provided. The measure was found in the Center for Quality Assessment and Improvement in Mental Health's measures inventory
Case Management for Dual Diagnosis. The number of dually diagnosed individuals enrolled in a health plan and participating in mental health case management services who respond to a biannual consumer survey at a specified point in time. The number of participants from the denominator who report that their mental health case manager assisted them to obtain substance abuse treatment. Multiple, including ambulatory. Administrative/patient survey. Tennessee Department of Mental Health and Mental Retardation
7-Day Hospital Readmission Rate (Psychiatric or Substance Abuse). The number of inpatients discharged from an acute mental health or substance abuse facility within a 90-day period. The number of patients in the denominator who were readmitted to the same type of facility (substance abuse or mental illness) within 7 days of discharge. Inpatient. Administrative/paper-based medical records. None provided.
14-Day Readmission Rate (Psychiatric or Substance Abuse). All patients admitted to a hospital and discharged with a primary diagnosis of a psychiatric or SUD during the first 6 months of a specified year. Patients in the denominator who are readmitted to a hospital within 14 calendar days following the index discharge. Inpatient. Administrative. Leslie et al., 2000. (No further information was provided. The measure was found in the Center for Quality Assessment and Improvement in Mental Health's measures inventory.)
180-Day Readmission Rate (Psychiatric or Substance Abuse). All patients admitted to a hospital and discharged with a primary diagnosis of a psychiatric or SUD during the first 6 months of a specified year. Patients in the denominator who are readmitted to a hospital within 180 calendar days following the index discharge. Inpatient. Administrative. Leslie et al., 2000. (No further information was provided. The measure was found in the Center for Quality Assessment and Improvement in Mental Health's measures inventory.)
Readmission Rates for Chemical Dependency. (This measure has been retired by the NCQA and is not part of the current HEDIS measure set.) All plan members hospitalized with a primary diagnosis of a substance abuse related disorder in a specified year. Those members from the denominator who are readmitted for related care of chemical dependency:

a) Within 1 year of discharge (count 1 readmission per member).
OR
b) Within 90 days of discharge.

Inpatient. Administrative. NCQA
Continuation after Substance-Related Treatment Initiation. All members of a health plan who have an outpatient visit for a primary diagnosis of a SUD during a specified period. Those members in the denominator who within 30 days of diagnosis utilize:

i) 3 substance abuse specialty outpatient visits, consecutive inpatient days, or consecutive residential days.

ii) 3 general medical outpatient visits for a primary diagnosis of substance abuse disorder.

iii) 3 visits consisting of either specialty substance abuse treatment or general medical treatment.

Ambulatory. Administrative/paper-based medical records. Washington Circle Group
COMMUNITY, POPULATION, AND PUBLIC HEALTH
Proportion of selected SUD patients who engage in timely treatment for alcohol and other drug dependence. All patients with an SUD diagnosis in a new treatment episode. Those members in the denominator who within 30 days of the start of a new treatment episode have engaged with SUD treatment. Multiple, including ambulatory. Not specified. VHA
Access to Substance Abuse Treatment (Adults). Estimate (based on survey of random-digit dialing sample of households) of state residents aged 18 and older who report having alcohol or drug-related problems (abuse or dependence as defined by DSM-IV criteria) who are medically indigent (annual household income <$10,000; receiving Medicaid or other public assistance; and have no medical insurance) and who desire substance-related treatment at a specified point in time. Number of residents (based on unduplicated count of client billings) from the denominator who have received services from a substance abuse treatment program funded by the state substance abuse agency. Multiple, including ambulatory (restricted to state-funded services). Patient survey. Texas Commission on Alcohol and Drug Abuse
Access to Substance Abuse Treatment (Children). The estimate (based on 2 public school-based prevalence surveys) of state residents 12-17 years of age who report having alcohol or drug-related problems (abuse or dependence as defined by certain problem-related survey questions) who are medically indigent (based on census, 200% federal poverty level) and who desire substance-related treatment at a specified point in time. Number of residents (based on unduplicated count of client billings) from the denominator who have received services from a substance abuse treatment program funded by the state substance abuse agency. Multiple, including ambulatory (restricted to state-funded services). Patient survey. Texas Commission on Alcohol and Drug Abuse
Proportion of patients with COD in a new treatment episode for COD with an administrative discharge. Patients with a new treatment episode for a COD. a) Proportion of patients with an administrative discharge on or after the start of the new treatment episode.

b) Patients with an administrative discharge within 90 days of the start of a new treatment episode.

c) Patients with an administrative discharge more than 90 days of the start of a new treatment episode.

d) Patients with no documentation of an administrative discharge.

e) For descriptive purposes, note reasons for discharge.

Unclear, we infer it includes inpatient and possibly ambulatory. Administrative/paper-based medical records. VHA
Homeless: percent of eligible homeless Veterans with an intake interview who receive timely mental health or SUD specialty services. Number of Veterans identified by intake interview as homeless or at imminent risk of homelessness who are eligible for VHA health care and indicate an interest in receiving VA psychiatric or substance abuse services. Number of Veterans in the denominator who receive timely* mental health or SUD specialty care.

*Timely care is defined as applicable inpatient, residential, or outpatient care occurring within the period of 30 days prior to and extending to 60 days after the index date. Refer to the original measure documentation for additional details.

Multiple, including ambulatory. Administrative/paper-based medical records, ambulatory, inpatient, residential, substance use treatment programs. VHA
Identification of alcohol and other drug services: summary of the number and percentage of members with an AOD claim who received the following chemical dependency services during the measurement year: any service, inpatient, intensive outpatient or partial hospitalization, and outpatient or emergency department. For commercial, Medicaid, and Medicare product lines, all member months during the measurement year for members with the chemical dependency benefit, stratified by age and sex. Members who received inpatient, intensive outpatient, partial hospitalization, outpatient and emergency department chemical dependency services (see the related "Numerator Inclusions/Exclusions" field). Multiple, including ambulatory. Administrative, EHR, paper-based medical records (health plan). NCQA
Chemical Dependency Utilization- Percent of Members Receiving Inpatient, Day/Night Care and Ambulatory Services. The number of members receiving chemical dependency services during the measurement year. The number of members receiving services in the following categories: any chemical dependency services; day/night chemical dependency services; ambulatory chemical dependency services. Reported by age and sex. Multiple, including ambulatory. Administrative. NCQA
Identification of alcohol and other drug services: summary of the number and percentage of members with an AOD claim who received the following chemical dependency services during the measurement year: any service, inpatient, intensive outpatient or partial hospitalization, and outpatient or emergency department. For commercial, Medicaid, and Medicare product lines, all member months during the measurement year for members with the chemical dependency benefit, stratified by age and sex. Members who received inpatient, intensive outpatient, partial hospitalization, outpatient and emergency department chemical dependency services (see the related "Numerator Inclusions/Exclusions" field). Multiple, including ambulatory. Administrative, EHR, paper-based medical records. NCQA
CARE COORDINATION
NQF #0004
IET.
Patients age 13 years of age and older who were diagnosed with a new episode of AOD dependency during the first 10½ months of the measurement year (e.g., January 1-November 15). Initiation of AOD Dependence Treatment:

Initiation of AOD treatment through an inpatient admission, outpatient visit, intensive outpatient encounter or partial hospitalization within 14 days of diagnosis.

Engagement of AOD Treatment:

Initiation of AOD treatment and 2 or more inpatient admissions, outpatient visits, intensive outpatient encounters or partial hospitalizations with any AOD diagnosis within 30 days after the date of the Initiation encounter (inclusive).

Multiple, including ambulatory. Administrative clinical data, electronic health/medical record, paper-based medical record. NCQA
Patients diagnosed with SUD in primary care were given a referral to specialty SUD care. Patients with SUD diagnosis. (1) Patients from the denominator who were already in Specialty SUD care.
OR
(2) Patients from the denominator not already in Specialty SUD care who were offered a referral to Specialty SUD care and who:

a) Refused referral to Specialty SUD care.

b) Did not complete a referral to Specialty SUD care.

c) Completed at least 1 visit to Specialty SUD care.

Multiple. Administrative/paper-based medical records. VHA
PERSON AND CAREGIVER CENTERED EXPERIENCE OUTCOMES
Substance Abuse Education in Primary Care. All enrollees of a health plan age 18 and older who had a primary care visit and responded to an enrollee survey within a specified time period. The total number of patients in the denominator who report that they were advised or given information about alcohol and/or drug abuse by the primary care provider. Multiple, including ambulatory. Patient survey. Washington Circle Group
Mental health/substance abuse: mean of patients' change scores on the "Substance Abuse" subscale of the BASIS-24® survey. Adult patients 18 years of age and older who completed a BASIS-24® survey at the beginning of psychiatric and/or substance abuse treatment and at another point in the treatment process.*

*Note: Completion of the second survey may be at discharge/termination or at another follow-up point during the episode of care.

The mean of patients' change scores on the "Substance Abuse" subscale of the BASIS-24® survey. Multiple, including ambulatory. Administrative/patient survey. McLean Hospital, Department of Mental Health Services Evaluation--Hospital/Medical Center (Eisen, Susan V., Ph.D.)
Proportion of patients abstinent from drugs OR alcohol in the 30 days prior to their last visit for outpatient specialty care treatment. Patients with SUD diagnosis in specialty mental health care. Patients from the denominator who were abstinent from drugs OR alcohol in the 30 days prior to their last visit for outpatient specialty care treatment during the study period. Ambulatory. Administrative/paper-based medical records. VHA
Family Involvement in Substance Abuse Treatment. The total number of members 18 and older enrolled in a health plan who report using AOD treatment services. The number of respondents from the denominator who report that their family members and/or significant other received preventive interventions. Likely multiple. Patient survey. Washington Circle Group
HIV ambulatory care satisfaction: percentage of HIV-positive adult patients who reported how often their plan covered alcohol and drug use treatment as much as they needed. HIV-positive adult patients 18 years of age and older continuously enrolled in a Medicaid managed care plan in the last 12 months and completed the survey. The number of patients who indicated "All of the time," "Most times," "Sometimes," "Rarely," "Never," or "Does Not Apply" to the item, "My plan covered alcohol and drug use treatment as much as I needed." Multiple. Patient survey. New York State Department of Health AIDS Institute
HIV ambulatory care satisfaction: percentage of HIV-positive adult patients who reported whether their substance use counselors explained to them in a way they could understand how their substance use treatment (for example, methadone) and their HIV medications might interact. HIV-positive adult patients 18 years of age and older engaged in a substance use treatment program who completed the survey. The number of patients who indicated "Strongly Disagree," "Disagree," "Agree," "Strongly Agree," or "Does Not Apply" to the item, "My substance use counselors explained to me in a way I could understand how my substance use treatment (for example, methadone) and my HIV medications might interact." Multiple. Patient survey. New York State Department of Health AIDS Institute

View full report

Preview
Download

"MATguidelines.pdf" (pdf, 1.59Mb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®